Skip to main content

. 1967 Dec 9;4(5579):592–595. doi: 10.1136/bmj.4.5579.592

Long-term trial of local guanethidine in treatment of eye signs of thyroid dysfunction and idiopathic lid retraction.

A L Crombie, A A Lawson

PMCID: PMC1749317 PMID: 6060118

593

Images in this article

Fig. 1
on p.593

Fig. 2
on p.593

Fig. 3
on p.594

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Gay A. J., Salmon M. L., Wolkstein M. A. Topical sympatholytic therapy for pathologic lid retraction. Arch Ophthalmol. 1967 Mar;77(3):341–344. doi: 10.1001/archopht.1967.00980020343009. [DOI] [PubMed] [Google Scholar]
Gay A. J., Wolkstein M. A. Topical guanethidine therapy for endocrine lid retraction. Arch Ophthalmol. 1966 Sep;76(3):364–367. doi: 10.1001/archopht.1966.03850010366012. [DOI] [PubMed] [Google Scholar]
LEE W. Y., MORIMOTO P. K., BRONSKY D., WALDSTEIN S. S. Studies of thyroid and sympathetic nervous system interrelationships. I. The blepharoptosis of myxedema. J Clin Endocrinol Metab. 1961 Nov;21:1402–1412. doi: 10.1210/jcem-21-11-1402. [DOI] [PubMed] [Google Scholar]
Sneddon J. M., Turner P. Adrenergic blockade and the eye signs of thyrotoxicosis. Lancet. 1966 Sep 3;2(7462):525–527. doi: 10.1016/s0140-6736(66)92881-9. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES